UBC (United Biosource)
Uniting real-world evidence and patient access to accelerate specialty therapy outcomes for biopharma.[UBC Homepage](https://ubc.com)
Visit WebsiteKnown For
Unites evidence generation with patient access services
Key Differentiators
- Unites evidence generation with patient access services
- proprietary tech platforms like UBC Pathways and Evidence Engine
Overview
United BioSource LLC (UBC) provides biopharma solutions specializing in real-world evidence generation, patient access hub services, and safety/risk management for specialty therapies. They partner with biopharmaceutical companies to mitigate risks, demonstrate product value under real-world conditions, and improve patient access and outcomes through integrated evidence and access services.UBC Homepage, UBC Our Story
Services & Capabilities
- Evidence development (modernized studies, late-stage research, RWE), pharmacovigilance, REMS, risk mitigation strategies, patient access hub services (benefit verification, prior auth/appeals, copay/PAP, nursing/adherence), reimbursement support, data analytics.[UBC Solutions](https://ubc.com/soluti
Competitive Position
- Unites evidence generation with patient access services
- proprietary tech platforms like UBC Pathways and Evidence Engine
- expertise in specialty therapies and RWE for rare/novel indicationsUBC Technology, UBC Our Story
Recent Developments
Jan 2026: Acquired Evidinno (RWE/HEOR); Appointed Dr. Massoud Toussi VP RWE. Nov 2025: Partnership w/ Datavant. Aug 2025: Launched RxLogix PV platform. Apr 2025: Everest Group PV Leader. 2024: Partnerships w/ Osmind, Thread (SitePlus); Citeline Awards finalist RWE (UBC Newsroom)
Client & Partner Ecosystem
Datavant (partner), Evidinno (acquired), Thread, RxLogix; follows/likely clients: Sanofi, Pfizer, GSK (inferred from LinkedIn); health systems like Duke, Cleveland Clinic in studies[UBC News](https://; BioPharma sponsors (generic mentions)
Technology Platform
UBC Pathways (patient access CRM & Connected Health eServices), UBC Evidence Engine (RWE platform)UBC Technology
Therapeutic Focus
Oncology, rare disease, cell & gene therapy, neurology (specialty therapies)UBC Insights, LinkedIn
Target Customers
Biopharmaceutical companies (brand teams), patients, prescribers, payersUBC Homepage, UBC Patient Access
Sources
Similar Vendors
100ms
Voice AI agents automating patient access workflows for pharma and specialty pharmacy to cut delays and boost adherence.
Accessia Health
Nonprofit providing comprehensive financial aid, case management, and legal support to rare/chronic disease patients beyond copays.
AccessSync
Integrated platform unifies payer data and tools to empower biopharma field teams for precise market access execution.
Agadia Systems
AI-powered utilization management platform automating prior authorization for 100M+ covered lives across 55+ health plan and PBM customers, with an emerging specialty drug ePA portal for pharma.
Apollo Care
Tech-driven copay, hub, and analytics solutions optimizing pharma patient access and commercial performance.
Apothesource
Custom software solutions modernizing healthcare IT for providers with pharmacy and government expertise.